Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE
- PMID: 22792202
- PMCID: PMC3390355
- DOI: 10.1371/journal.pone.0039973
Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE
Abstract
Background: There is a strong need for a recombinant subunit vaccine against fowl cholera. We used a reverse vaccinology approach to identify putative secreted or cell surface associated P. multocida proteins that may represent potential vaccine candidate antigens.
Principal findings: A high-throughput cloning and expression protocol was used to express and purify 71 recombinant proteins for vaccine trials. Of the 71 proteins tested, only one, PlpE in denatured insoluble form, protected chickens against fowl cholera challenge. PlpE also elicited comparable levels of protection in mice. PlpE was localized by immunofluorescence to the bacterial cell surface, consistent with its ability to elicit a protective immune response. To explore the role of PlpE during infection and immunity, a plpE mutant was generated. The plpE mutant strain retained full virulence for mice.
Conclusion: These studies show that PlpE is a surface exposed protein and was the only protein of 71 tested that was able to elicit a protective immune response. However, PlpE is not an essential virulence factor. This is the first report of a denatured recombinant protein stimulating protection against fowl cholera.
Conflict of interest statement
Figures


Similar articles
-
Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).Vaccine. 2007 May 22;25(21):4140-8. doi: 10.1016/j.vaccine.2007.03.005. Epub 2007 Mar 20. Vaccine. 2007. PMID: 17449151
-
Immunoprotective efficacy of Escherichia coli-derived outer membrane vesicles displaying PlpE protein of Pasteurella multocida.Vaccine. 2025 Jan 12;44:126532. doi: 10.1016/j.vaccine.2024.126532. Epub 2024 Nov 26. Vaccine. 2025. PMID: 39603075
-
Candidate vaccine antigens and genes in Pasteurella multocida.J Biotechnol. 1999 Aug 20;73(2-3):83-90. doi: 10.1016/s0168-1656(99)00111-x. J Biotechnol. 1999. PMID: 10486918 Review.
-
Protection of chickens from fowl cholera by vaccination with recombinant adhesive protein of Pasteurella multocida.Vaccine. 2008 May 2;26(19):2398-407. doi: 10.1016/j.vaccine.2008.02.051. Epub 2008 Mar 14. Vaccine. 2008. PMID: 18403068
-
Immunogens of Pasteurella.Vet Microbiol. 1993 Nov;37(3-4):353-68. doi: 10.1016/0378-1135(93)90034-5. Vet Microbiol. 1993. PMID: 8116191 Review.
Cited by
-
Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers.Sci Rep. 2021 Apr 26;11(1):8885. doi: 10.1038/s41598-021-88299-0. Sci Rep. 2021. PMID: 33903662 Free PMC article.
-
PlpE Epitopes of Pasteurella multocida Fusion Protein as Novel Subunit Vaccine Candidates.Adv Biomed Res. 2020 Aug 28;9:43. doi: 10.4103/abr.abr_245_19. eCollection 2020. Adv Biomed Res. 2020. PMID: 33072655 Free PMC article.
-
Combinations but Not a Single PlpE Epitope Induces Host Protective Immunity against Pasteurella multocida.Infect Immun. 2023 Mar 15;91(3):e0027222. doi: 10.1128/iai.00272-22. Epub 2023 Feb 23. Infect Immun. 2023. PMID: 36815793 Free PMC article.
-
Genomic characterization and comparative genomic analysis of HS-associated Pasteurella multocida serotype B:2 strains from Pakistan.BMC Genomics. 2023 Sep 14;24(1):546. doi: 10.1186/s12864-023-09626-5. BMC Genomics. 2023. PMID: 37710174 Free PMC article.
-
Occurrence of Pasteurella multocida among pigs with respiratory disease in China between 2011 and 2015.Ir Vet J. 2017 Jan 10;70:2. doi: 10.1186/s13620-016-0080-7. eCollection 2017. Ir Vet J. 2017. PMID: 28078081 Free PMC article.
References
-
- Hansson M, Nygren PA, Stahl S. Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem 32 (Pt. 2000;2):95–107. - PubMed
-
- Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science. 2000;287:1816–1820. - PubMed
-
- Ross BC, Czajkowski L, Hocking D, Margetts M, Webb E, et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine. 2001;19:4135–4142. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources